Cannabis Bioscience International Holdings, Inc. (CBIH)

CBIH Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	0.3	0.25	0.32	0.21	0.76
Revenue Growth (YoY)	21.77%	-21.46%	47.37%	-71.78%	162.46%
Cost of Revenue	0.04	0.05	0.09	0.05	0.11
Gross Profit	0.26	0.2	0.22	0.17	0.65
Selling, General & Admin	0.68	0.69	1.21	1.06	0.77
Operating Expenses	0.68	0.69	1.21	1.06	0.77
Operating Income	-0.42	-0.49	-0.98	-0.89	-0.12
Interest Expense	-0.14	-0.15	-0.09	-0.05	-0.04
Other Non Operating Income (Expenses)	-0.01	-0.01	-	-	-
EBT Excluding Unusual Items	-0.57	-0.65	-1.07	-0.94	-0.16
Other Unusual Items	0.02	-	0.04	0.05	-
Pretax Income	-0.55	-0.65	-1.03	-0.89	-0.16
Net Income	-0.55	-0.65	-1.03	-0.89	-0.16
Net Income to Common	-0.55	-0.65	-1.03	-0.89	-0.16
Shares Outstanding (Basic)	10,716	10,318	9,002	8,091	8,246
Shares Outstanding (Diluted)	10,716	10,318	9,002	8,091	8,246
Shares Change (YoY)	3.86%	14.62%	11.26%	-1.89%	8.77%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00
Gross Margin	86.77%	81.67%	70.50%	78.25%	85.78%
Operating Margin	-139.05%	-195.36%	-310.38%	-413.09%	-15.27%
Profit Margin	-181.12%	-261.75%	-325.92%	-411.75%	-20.91%
EBIT	-0.42	-0.49	-0.98	-0.89	-0.12
EBIT Margin	-139.05%	-195.36%	-	-	-15.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.